Dorman Products Stock Price and Value Analysis

Dorman Products (NasdaqGS:DORM) in our automated value investing analysis, with the cash flow history and price comparison below.

Key Facts

Advertisement helps keep Trendshare free for most readers.

Hold-time calculator

Estimate how long you need to hold Dorman Products to reach your target.

Target type

DORM Free Cash Flow Trend

Free Cash Flow trendline for DORM
Free Cash Flow trendline for Dorman Products
CSV

Based on historical returns, we believe that Dorman Products can grow its free cash at a rate of about 7%. That's positive!

AdvantagesDisadvantagesNeutral
  • This company is making money at a decent rate.
  • This company is solid.
  • This company has wild ups and downs.
  • This stock looks overpriced.
  • This company pays no dividend.

Inside the DORM Numbers

DORM Price
(Dorman Products stock price per share)
$131.53
[?] DORM Fair Price
(based on intrinsic value)
$76.46
[?] DORM Safety Price (based on a variable margin of safety) $49.70
Try your own return

The fair price above uses a 10.1% discount rate, the long-run US stock return (10.1% geometric, 1926 to 2025, from Bessembinder's working paper, updated 2026-11-09), and 2.5% terminal growth. A higher rate suits a higher return target and gives a lower value.

Value per share:

[?] PE Ratio versus Sector 64% higher than other Consumer Cyclical stocks
[?] PE Ratio versus Industry 20% higher than other Auto Parts stocks
[?] Cash Yield 1.09%
[?] Free Cash Flow Jitter 54%

Insider Activity Summary

No open-market insider buys or sells are recorded for the last 12 months.

This stock has short interest! This means that people have shorted it.

Why does that matter? They've made a bet that price will decrease from where they bought it. Maybe there are financial problems, or maybe there's a value play.

As of the latest analysis, there are 1,533,876 shares shorted. With 25,931,153 shares available for purchase and an average trading volume over the past 10 trading days of 196,540, it would take at least 7.8 days for all of the short holders to cover their shorts.

Related guides: good annual rate of return · high-yield stocks · forecasting earnings growth

Free Cash Flow by Fiscal Year

How to read this: free cash flow in plain terms, free cash flow jitter.

Each year names the SEC filer that reported it, so a change of filer shows up here.

Fiscal yearSEC filer (CIK)Free cash flow (USD millions)
2009 868780 19.8
2010 868780 21.1
2011 868780 25.6
2012 868780 35
2013 868780 45.5
2014 868780 39.2
2015 868780 69.6
2016 868780 98.7
2017 868780 70.1
2018 868780 53.7
2019 868780 70.9
2020 868780 129
2021 868780 77.3
2022 868780 15.9
2023 868780 179
2024 868780 200
2025 868780 77.8

Download the yearly data as CSV.

Cash Conversion

How to read this: what free cash flow is, why earnings matter.

Over the 17 fiscal years from 2009 to 2025 with positive net income, operating cash flow totaled $1,595 million against net income of $1,775 million, or 0.90 times.

In 2025, operating cash flow was 0.56 times net income, compared with 0.77 times for the earliest three years (2009 to 2011).

In 2025, capital expenditures were $38 million, 33.4% of operating cash flow of $114 million, which leaves an estimated $75.7 million after capex. Across the 17 years with reported capex, it averaged 26.7% of operating cash flow. This uses that year's own capital expenditures, not the five-year average behind the free cash flow table, so the two can differ.

Cash conversion in 2025 was 0.56, below 0.80, so under 80% of reported net income arrived as operating cash. Gaps like this come from non-cash gains or from cash tied up in receivables, inventory or other working capital.

Fiscal yearNet income (USD millions)Operating cash flow (USD millions)Capital expenditures (USD millions)Operating cash flow / net income
2009 26.5 27.6 7.8 1.04
2010 46.1 30.7 11.5 0.67
2011 53.3 38.1 18.1 0.71
2012 71 48.9 18.1 0.69
2013 81.9 61.6 24.7 0.75
2014 90 59.6 29.9 0.66
2015 92.3 92.1 21.7 1.00
2016 106 122 20.1 1.15
2017 107 94.2 24.4 0.88
2018 134 78.1 26.1 0.58
2019 83.8 95.3 29.6 1.14
2020 107 152 15.4 1.42
2021 132 100 19.8 0.76
2022 122 41.7 37.9 0.34
2023 129 209 44 1.62
2024 190 231 39.4 1.22
2025 204 114 38 0.56

Where the Cash Went

How to read this: why companies buy back shares, dividend yield explained.

Over the 10 fiscal years from 2016 to 2025 with dividend or share repurchase facts, estimated free cash flow totaled $972 million. That estimate uses the average of up to five years of capital expenditures, not each year's own, so it is not a reported figure.

In 10 of the 10 years, cash spent repurchasing shares was at least 5% of that year's estimated free cash flow, and in those years it totaled $447 million. Smaller amounts are left out of this sentence because they can be shares withheld to pay employees' taxes on stock awards.

In 2025, cash spent repurchasing shares was $41.5 million, 53.3% of estimated free cash flow of $77.8 million.

Fiscal yearEstimated free cash flow (USD millions)Dividends paid (USD millions)Cash spent repurchasing shares (USD millions)Total returned (USD millions)Total as a percent of estimated free cash flow
2016 98.7 n/a 24.7 24.7 25.0%
2017 70.1 n/a 76.1 76.1 108.6%
2018 53.7 n/a 45.4 45.4 84.5%
2019 70.9 n/a 41.3 41.3 58.3%
2020 129 n/a 38.7 38.7 30.0%
2021 77.3 n/a 62.8 62.8 81.2%
2022 15.9 n/a 19.9 19.9 125.2%
2023 179 n/a 16.5 16.5 9.2%
2024 200 n/a 80 80 40.1%
2025 77.8 n/a 41.5 41.5 53.3%

Free cash flow here is an estimate: operating cash flow less the average of up to five years of capital expenditures. Cash spent repurchasing shares can include shares withheld to pay employees' taxes on stock awards. The entry n/a means the filings gave no usable figure, not that the amount was zero. Source: the company's annual reports to the SEC.

Revenue and Cash Margin

How to read this: earnings and margins.

Revenue was $377 million in 2009 and $2,130 million in 2025, a compound annual growth rate of 11.4% over 16 years.

Revenue rose 6.0% from 2024 to 2025.

Our estimated free cash flow was $77.8 million in 2025, 3.7% of revenue. In 2009 the estimated margin was 5.2%. This estimate charges each year with the average of up to five years of capital expenditures, so it is not the free cash flow the company reported.

Fiscal yearRevenue (USD millions)Estimated free cash flow (USD millions)Estimated free cash flow / revenue
2009 377 19.8 5.2%
2010 438 21.1 4.8%
2011 513 25.6 5.0%
2012 570 35 6.1%
2013 664 45.5 6.9%
2014 751 39.2 5.2%
2015 803 69.6 8.7%
2016 860 98.7 11.5%
2017 903 70.1 7.8%
2018 974 53.7 5.5%
2019 991 70.9 7.2%
2020 1,093 129 11.8%
2021 1,345 77.3 5.7%
2022 1,734 15.9 0.9%
2023 1,930 179 9.3%
2024 2,009 200 9.9%
2025 2,130 77.8 3.7%

Balance Sheet

How to read this: how debt and assets are compared, the current ratio.

In 2025, cash and equivalents were $49.4 million against total liabilities of $1,016 million, or 4.9% of total liabilities. Total liabilities include everything the company owes, not only borrowed money.

Total liabilities were 40.8% of total assets in 2025, compared with 18.6% in 2010, an increase of 22.2 percentage points.

Stockholders equity was $1,477 million in 2025, compared with $263 million in 2010, a rise of 461.3%.

Based on our estimated free cash flow, cash flow return on invested capital (CROIC) was 4.0% in 2025. Invested capital here is total assets less cash and current liabilities.

Fiscal yearTotal assets (USD millions)Cash and equivalents (USD millions)Total liabilities (USD millions)Stockholders equity (USD millions)
2010 323 30.5 60 263
2011 377 50.2 59.6 317
2012 413 27.7 79.8 333
2013 529 60.6 116 414
2014 558 47.7 95.7 462
2015 622 78.7 104 518
2016 712 149 110 602
2017 766 71.7 131 635
2018 978 43.5 250 728
2019 1,041 68.4 267 774
2020 1,221 156 367 854
2021 1,673 58.8 740 933
2022 2,342 46 1,299 1,043
2023 2,292 36.8 1,124 1,168
2024 2,425 57.1 1,131 1,293
2025 2,493 49.4 1,016 1,477

What the Price Implies

How to read this: discounted cash flow, intrinsic value.

At today's price of $131.53, our model's value equals that price if free cash flow grows an average of 22.0 percent a year over the 10 projection years. Our model assumes 6.6 percent a year for this stock, so the price implies growth of 22.0 percent, which is above the 6.6 percent our model assumes. This is the growth the price implies under our model, not a forecast of growth or a price target.

At 22.0 percent a year, free cash flow would grow about 7.3 times over the 10 years.

The table shows the same calculation at a price 20 percent lower and 20 percent higher than today's price, and the model's own growth rate at its fair price.

The model starts from the company's average free cash flow of $42.4 million, grows it over 10 years along the year-by-year growth path stored for this stock (the pace fades over the years, and the implied rate keeps that shape, so the rates here are 10-year averages), discounts it at 10.1 percent a year, adds a terminal value that grows 2.5 percent a year after year 10, adds the company's net worth, and divides by shares outstanding.

The baseline is the company's average free cash flow, and cyclical companies can mislead it.

CasePrice per shareAverage annual free cash flow growth
20 percent below the current price $105.22 16.6%
Current price $131.53 22.0%
20 percent above the current price $157.84 25.9%
Our model (stored fair price) $76.46 6.6%

Model assumptions: 10.1 percent discount rate, 2.5 percent terminal growth, 10 projection years. To try your own growth rate, use the intrinsic value calculator on this page. It uses a simpler single-rate model, so its results will not match the figures above exactly.

Price Versus Our Estimated Value

Free cash flow was positive in all 17 fiscal years we have for Dorman Products under its current SEC filer.

Dorman Products is priced at $131.53, above our fair value estimate of $76.46 and its safe value of $49.70.

The latest three years average $152 million in free cash flow against $22.1 million for the earliest three, which is a sharp rise.

Free cash flow is volatile from year to year, with a variability measure of 54%.

Dividends are not in our data for Dorman Products.

These figures are automated calculations from SEC filings and the recent price. They are not a recommendation to buy or sell. See how we estimate value.

Compared With Its Sector and Industry

How to read this: the price to earnings ratio.

Its trailing P/E ratio is 64% above the average for stocks in the Consumer Cyclical sector.

Its trailing P/E ratio is 20% above the average for stocks in the Auto Parts industry.

A P/E ratio depends on trailing earnings, which one-time items can distort, so a lower P/E is not by itself evidence of value.

Closest Industry Peers

These are companies in the Auto Parts industry, the ones closest in market capitalization to Dorman Products, limited to companies whose pages we publish. The figures come from our latest data for each company.

CompanyMarket cap (USD millions)P/EDividend yieldCash yieldPrice versus our estimate
Dorman Products (DORM) 3,879 19.6 - 1.1% 72% above
Gentex Corporation (GNTX) 3,850 10.0 2.5% 8.7% 68% below
Lear Corporation (LEA) 4,917 8.8 2.9% - 2% below
Patrick Industries (PATK) 2,588 20.9 2.3% 2.8% 10% below
LCI Industries (LCII) 2,400 12.1 4.7% - 76% above
Dana Incorporated (DAN) 2,152 - 1.9% 15.1% 61% below
Visteon Corporation (VC) 1,978 21.8 1.7% - 39% above

Industry labels are approximate, and companies in one industry can run quite different businesses, so a peer may not be a close match.

Ratios on different fiscal calendars are not strictly comparable, and a trailing P/E can be distorted by one-time items.

SEC Filer History

Every fiscal year on this page is reported by one SEC filer, CIK 868780.

Each figure on this page comes from that filer.

Risks to This Analysis

How to read this: understanding investment risk.

  • Free cash flow is volatile from year to year, so the estimates depend heavily on which years are included.
  • These figures are automated calculations from SEC filings and the recent price. They may contain errors, and they do not reflect lawsuits, management changes, or other events the filings do not show.

How This Page Is Made

Latest annual report used
Fiscal year 2025
Price and market data last refreshed
2026-11-21
Model assumptions last reviewed
2026-11-09

Company figures come from the annual reports (Form 10-K) that each company files with the SEC, read from the SEC EDGAR company facts data. The share price and other market data come from a market data provider.

Free cash flow here is operating cash flow minus capital spending. To keep one unusual year from swinging the result, each year is charged with the average of up to five years of capital spending, so the figure is an estimate and not the free cash flow a company reports.

The fair price is the present value of ten years of projected free cash flow plus a terminal value, discounted at 10.1 percent a year, the long-run return of US stocks, with 2.5 percent growth after year ten. The figures on this page are estimates, not advice.

This analysis covers US companies that file 10-K annual reports. Free cash flow describes banks, real estate investment trusts and funds poorly, so treat their figures with extra caution. In the cash returned and balance sheet tables, a value of zero is treated as a gap in the data, not as a real zero.

Read the filings yourself: DORM annual reports (10-K) on SEC EDGAR. To try your own growth rate, use the intrinsic value calculator on this page. Our editorial standards explain how Trendshare handles its sources and corrections.

Advertisement supports free stock analysis content.

Questions to Answer Before You Invest in DORM

Does Dorman Products have a coherent story? Does it have a plan to continue to make money? Is it worth your time? Only you can decide where to go from here. Our investment guide helps you ask the right questions, including how to buy stocks. Use these research links for more information.

Worked example: DORM

This example shows how we apply the Trendshare checklist to DORM: earnings power, cash generation, valuation, and margin of safety.

We check: business quality, free cash flow, P/E, and margin of safety.

  1. Step 1 — Snapshot

    • Price: 131.53
    • Market cap: $3.9B
    • EPS: 6.71
  2. Step 2 — Valuation checks

    • P/E: 19.602
    • FCF yield: 1.1%
    • Date checked: Nov 21, 2026
  3. Step 3 — Margin of safety

    • Compare price to fair value and safety price.
    • Look for durable cash generation and reasonable leverage.
    • Decide if it passes your personal checklist.